Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Personalised Medicine Market: By Technology: Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Others; By Application; By Product; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments

Global Personalised Medicine Market Outlook

The global personalised medicine market size was estimated at USD 1.8 trillion in 2020 and is expected to grow over the forecast period of 2022-2027 at a CAGR of 11.2%. Personalised medicine promises a paradigm shift in the delivery of diagnosis as the therapy care is based on the information leveraged from an individual patient’s holistic perspective.

 

Global Personalized Medicine Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Segmentation

Personalised medicine is a kind of medical care in which treatment is customised for an individual patient. The global personalised medicine market can be divided based on segments like technology, application, and product.

 

Global Personalized Medicine Market By Application

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The personalised medicine market can be broadly categorised based on its application into:

  • Oncology
  • CNS
  • Immunology
  • Respiratory
  • Other

The industry can be divided on the basis of its technology like big data analytics, bioinformatics, gene sequencing, drug discovery, and companion diagnostics, among others. The industry can be divided based on its product as PM diagnostics, PM therapeutics, personalised medical care, and personalised nutrition and wellness. PM diagnostics is subdivided into genetic testing, direct-to-consumer (DTC) diagnostics, esoteric lab services, and esoteric lab tests. PM therapeutics is also further subdivided into pharmaceuticals, genomic medicine, and medical devices. Personalised medical care, meanwhile, is subdivided into telemedicine, health information technology, and disease management. Personalised nutrition and wellness can be further categorised into retail nutrition, complementary medicine, and alternative medicine.

The EMR report looks into the regional markets of personalised medicine like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific regions.

 

Global Personalized Medicine Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The proliferation of sequencing methodologies, in particular, Next Generation Sequencing, is anticipated to drive the personalised medicine market growth owing to the increasing sequencing costs and the growth of the Human Genome Project in the field of genomics. Increasing cancer incidence, which boosts the demand for personalised diagnosis of cancer and therapy, is also one of the main variables responsible for the personalised medicine market growth. The growing expenditure on cancer is also one of the drivers for the development of the personalised medicine market.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global personalised medicine market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Illumina Inc.         
  • GE Healthcare  
  • Pfizer Inc.  
  • Novartis AG     
  • Abbott Laboratories    
  • Asuragen Inc.    
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Technology, Application, Product, Region
Breakup by Technology Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Others
Breakup by Application Oncology, CNS, Immunology, Respiratory, Other
Breakup by Product PM Diagnostics, PM Therapeutics, Personalised Medical Care, Personalised Nutrition & Wellness
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Illumina Inc., GE Healthcare, Pfizer Inc., Asuragen Incorporated, Novartis AG, Abbott Laboratories, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Personalised Medicine Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Personalised Medicine Historical Market (2017-2021) 
    8.3    Global Personalised Medicine Market Forecast (2022-2027)
    8.4    Global Personalised Medicine Market by Technology
        8.4.1    Big Data Analytics
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Bioinformatics
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Gene Sequencing
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
        8.4.4    Drug Discovery
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2017-2021)
            8.4.4.3    Forecast Trend (2022-2027)
        8.4.5    Companion Diagnostics
            8.4.5.1    Market Share
            8.4.5.2    Historical Trend (2017-2021)
            8.4.5.3    Forecast Trend (2022-2027)
        8.4.6    Others
    8.5    Global Personalised Medicine Market by Application
        8.5.1    Oncology
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    CNS
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Immunology
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
        8.5.4    Respiratory
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2017-2021)
            8.5.4.3    Forecast Trend (2022-2027)
        8.5.5    Others
    8.6    Global Personalised Medicine Market by Product
        8.6.1    PM Diagnostics
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
            8.6.1.4    Breakup by Type
                8.6.1.4.1    Genetic Testing
                8.6.1.4.2    Direct-To-Consumer Diagnostics
                8.6.1.4.3    Esoteric Lab Services
                8.6.1.4.4    Esoteric Lab Tests
        8.6.2    PM Therapeutics
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
            8.6.2.4    Breakup by Type
                8.6.2.4.1    Pharmaceuticals
                8.6.2.4.2    Genomic Medicine
                8.6.2.4.3    Medical Devices
        8.6.3    Personalised Medical Care
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021)
            8.6.3.3    Forecast Trend (2022-2027)
            8.6.3.4    Personalised Medical Care by Type
                8.6.3.4.1    Telemedicine
                8.6.3.4.2    Health information Technology
                8.6.3.4.3    Disease Management
        8.6.4    Personalised Nutrition and Wellness
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2017-2021)
            8.6.4.3    Forecast Trend (2022-2027)
            8.6.4.4    Breakup by Type
                8.6.4.4.1    Retail Nutrition
                8.6.4.4.2    Complementary Medicine
                8.6.4.4.3    Alternative Medicine
    8.7    Global Personalised Medicine Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    Illumina Inc.
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    GE Healthcare
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3     Pfizer Inc.
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Novartis AG
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    Abbott Laboratories 
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    Asuragen Inc.
            11.2.6.1    Company Overview
            11.2.6.2    Product Portfolio
            11.2.6.3    Demographic Reach and Achievements
            11.2.6.4    Certifications
        11.2.7    Others
12    Industry Events and Developments

 

List of Key Figures and Tables

1.    Global Personalised Medicine Market: Key Industry Highlights, 2016 and 2026
2.    Global Personalised Medicine Historical Market: Breakup by Technology (USD Million), 2017-2021
3.    Global Personalised Medicine Market Forecast: Breakup by Technology (USD Million), 2022-2027
4.    Global Personalised Medicine Historical Market: Breakup by Application (USD Million), 2017-2021
5.    Global Personalised Medicine Market Forecast: Breakup by Application (USD Million), 2022-2027
6.    Global Personalised Medicine Historical Market: Breakup by Product (USD Million), 2017-2021
7.    Global Personalised Medicine Market Forecast: Breakup by Product (USD Million), 2022-2027
8.    Global Personalised Medicine Historical Market: Breakup by Region (USD Million), 2017-2021
9.    Global Personalised Medicine Market Forecast: Breakup by Region (USD Million), 2022-2027
10.    North America Personalised Medicine Historical Market: Breakup by Country (USD Million), 2017-2021
11.    North America Personalised Medicine Market Forecast: Breakup by Country (USD Million), 2022-2027
12.    Europe Personalised Medicine Historical Market: Breakup by Country (USD Million), 2017-2021
13.    Europe Personalised Medicine Market Forecast: Breakup by Country (USD Million), 2022-2027
14.    Asia Pacific Personalised Medicine Historical Market: Breakup by Country (USD Million), 2017-2021
15.    Asia Pacific Personalised Medicine Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Latin America Personalised Medicine Historical Market: Breakup by Country (USD Million), 2017-2021
17.    Latin America Personalised Medicine Market Forecast: Breakup by Country (USD Million), 2022-2027
18.    Middle East and Africa Personalised Medicine Historical Market: Breakup by Country (USD Million), 2017-2021
19.    Middle East and Africa Personalised Medicine Market Forecast: Breakup by Country (USD Million), 2022-2027
20.    Global Personalised Medicine Market Structure

Key Questions Answered in the Report

In 2020, the global personalised medicine market attained a value of nearly USD 1.8 trillion.

The market is estimated to witness a healthy growth, expanding at a CAGR of 11.2% in the forecast period of 2022-2027.

The major drivers of the market include the advancements in sequencing methodologies, paradigm shift in the delivery of diagnosis, and the growth of the human genome project in the field of genomics.

The increasing prevalence of cancer is boosting the demand for personalised medical care and therapy, which is expected to be a key trend guiding the growth of the industry.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Big data analytics, bioinformatics, gene sequencing, drug discovery, and companion diagnostics, among others are the major technologies of the product in the market.

PM diagnostics (genetic testing, direct-to-consumer (DTC) diagnostics, esoteric lab services, and esoteric lab tests), PM therapeutics (pharmaceuticals, genomic medicine, and medical devices), personalised medical care (telemedicine, health information technology, and disease management), and personalised nutrition and wellness (retail nutrition, complementary medicine, and alternative medicine) are the different products available in the market.

Oncology, CNS, immunology, and respiratory, among others are the significant applications of the product in the market.

The major players in the industry are Illumina Inc., GE Healthcare, Pfizer Inc., Asuragen Incorporated, Novartis AG, Abbott Laboratories, among others.

Analyst Review

The global personalised medicine market attained a value of USD 1.8 trillion in 2020, driven by the development of the gene sequencing technology. Aided by the growing R&D activities and increasing preference for personalised medical care among the patients suffering from cancer, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 11.2%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. By technology, the industry is segmented into big data analytics, bioinformatics, gene sequencing, drug discovery, and companion diagnostics, among others. Based on product, the market is divided into PM diagnostics (genetic testing, direct-to-consumer (DTC) diagnostics, esoteric lab services, and esoteric lab tests), PM therapeutics (pharmaceuticals, genomic medicine, and medical devices), personalised medical care (telemedicine, health information technology, and disease management), and personalised nutrition and wellness (retail nutrition, complementary medicine, and alternative medicine). On the basis of application, the market is segmented into oncology, CNS, immunology, and respiratory, among others. The major regional markets for personalised medicine are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Illumina Inc., GE Healthcare, Pfizer Inc., Asuragen Incorporated, Novartis AG, Abbott Laboratories, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER